FDA’s LDT Rule: Navigating Digital Pathology AI’s New Regulatory Era
The era of regulatory flexibility for laboratory-developed diagnostics is rapidly drawing to a close, fundamentally reshaping the field for digital pathology and AI-driven diagnostic tools.…